tradingkey.logo
搜索

Treace Medical Concepts Inc

TMCI
添加自选
4.210USD
-0.020-0.47%
收盘 07/02, 13:00美东报价延迟15分钟
272.75M总市值
亏损市盈率 TTM

Treace Medical Concepts Inc

4.210
-0.020-0.47%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.47%

5天

-5.61%

1月

+14.09%

6月

+68.40%

今年开始到现在

+71.84%

1年

-31.88%

关键数据
4.290今开
4.425最高
460.66K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
0.71%换手率
4.230昨收
4.105最低
1.36M成交额
亏损市盈率静
3.53市净率
0.00%股息率 TTM
-31.31%ROA
7.78052周最高
0.38量比
-55.74M净利润
64.79M总股本
-0.9565每股收益TTM
1.29Beta
-66.88%ROE
1.17052周最低
7.57%振幅
79.26%毛利率
272.75M总市值
2.90回报/风险
5.04%风险率

TradingKey Treace Medical Concepts Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Treace Medical Concepts Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名118/204位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价4.00。中期看,股价处于上升通道。近一个月,市场表现较强,技术面和基本面综合得分较高,较强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Treace Medical Concepts Inc评分

相关信息

行业排名
118 / 204
全市场排名
283 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

Treace Medical Concepts Inc亮点

亮点风险
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
利润高增长
公司净利润处于行业前列,最新年度总收入212.69M美元
估值高估
公司最新PE估值-4.40,处于3年历史高位
机构减仓
最新机构持股37.97M股,环比减少29.23%
活跃度增加
近期活跃度增加,过去20天平均换手率0.99

分析师目标

根据 5 位分析师
持有
评级
4.000
目标均价
-5.44%
涨幅空间

Treace Medical Concepts Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Treace Medical Concepts Inc简介

Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
公司代码TMCI
公司Treace Medical Concepts Inc
CEOTreace (John T)
网址https://www.treace.com/

常见问题

Treace Medical Concepts Inc(TMCI)的当前股价是多少?

Treace Medical Concepts Inc(TMCI)的当前股价是 4.21。

Treace Medical Concepts Inc的股票代码是什么?

Treace Medical Concepts Inc的股票代码是TMCI。

Treace Medical Concepts Inc股票的52周最高点是多少?

Treace Medical Concepts Inc股票的52周最高点是7.78。

Treace Medical Concepts Inc股票的52周最低点是多少?

Treace Medical Concepts Inc股票的52周最低点是1.17。

Treace Medical Concepts Inc的市值是多少?

Treace Medical Concepts Inc的市值是272.75M。

现在Treace Medical Concepts Inc(TMCI)的股票是买入、持有还是卖出?

根据分析师评级,Treace Medical Concepts Inc(TMCI)的总体评级为signal_hold,目标价格为4.00。

Treace Medical Concepts Inc(TMCI)股票的每股收益(EPS TTM)是多少

Treace Medical Concepts Inc(TMCI)股票的每股收益(EPS TTM)是-0.93。